You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH)擬售天士營銷股權予重慶醫藥 預計構成重大資產重組
格隆匯 12-16 18:59

格隆匯12月16日丨天士力(600535.SH)公佈,20191216日,公司重慶醫藥(集團)股份有限公司(“重慶醫藥”)簽署了《框架協議》,就出售公司控股子公司天津天士力醫藥營銷集團股份有限公司(“天士營銷”)股權進行了約定。

根據《框架協議》,重慶醫藥擬通過支付現金對價的方式收購公司直接及間接持有天士營銷87.47%的股權及天士營銷其他股東所持有天士營銷的股份

此次交易擬按照20191231日作為審計、評估基準日,雙方將參考評估結論對最終交易對價進行進一步協商。

天士營銷主要負責公司原醫藥商業業務板塊,通過此次資產出售,公司將進一步聚焦醫藥工業,繼續推進現代中藥、生物藥和化學藥的協同發展,構築創新醫藥研發集羣。同時,公司擬通過此次交易與重慶醫藥在醫藥商業領域建立長期良好的合作關係,最終實現合作共贏的戰略目標。

根據《上市公司重大資產重組管理辦法》的有關規定,此次交易預計將構成重大資產重組,此次交易不會導致公司控制權的變更。

公司將按照上海證券交易所的有關規定,儘快聘請獨立財務顧問、法律顧問、審計機構和評估機構等相關中介機構開展相關工作。公司將按照相關法律、法規及《公司章程》的規定將此次資產出售事項提交公司董事會及股東大會審議。

天士營銷合併報表口徑2018年度營業收入總額約116.59億元,淨利潤約1億元,佔公司2018年度營業收入總額和淨利潤的比例分別為64.81%6.30%。此次重大資產出售預計對公司未來淨利潤不構成重大不利影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account